RACHESKY MARK H MD
Director
PurchaseAlert
- Shares
- 15,804,919
- Price
- —
- Value
- —
SEC EDGAR · Forms 3/4/5Updated through Oct 30, 2026•49 filings
LION
Lionsgate Studios Corp.
No net buying or selling imbalance over the last 3 months
No net buyers or sellers account for the net balance. There is no cluster of three distinct buyers within 30 days. We found no CEO/CFO purchases over 12 months.
How to read this signal
Only open-market P purchases and S sales count toward the signal. Vesting, options, taxes and gifts remain in the source data but do not trigger alerts. Rule 10b5-1 trades are shown as informational.
3-month balance
$0.00
0 buyers · 0 sellers
12-month purchases
$0.00
1 distinct insiders
12-month sales
$2,024,049
4 distinct insiders
Highlighted alerts
15
0 Rule 10b5-1 trades treated as informational
Buying cluster · 30 days
Fewer than three distinct buyers
CEO/CFO purchases · 12 months
No executive purchases found
Get LION insider trades by API
The same filtered trades as JSON for your scripts, alerts or AI agent, for 5,500+ US companies — plus sentiment, news, financials and breakout setups. Free · every API · 1,000 requests a month · no card required.
LION overview: breakout setup, X sentiment and insiders in one page →
Form 4 raw → Raspberry
The value is in what we do not call a signal.
The SEC XML stores every transaction. Raspberry keeps that evidence, reads the footnotes and separates voluntary open-market activity from vesting, option exercises, gifts, tax withholding, stock purchase and dividend reinvestment plans and pre-programmed 10b5-1 trades.
100
Raw transactions
Everything returned by the filing
15
Voluntary view
P/S trades after deterministic checks
87
Administrative noise
Stored, never alerted
0
10b5-1
Shown as informational
SEC ownership XML facts
- Code
- A
- Shares
- 5,362
- Price
- $11.19
- Footnotes
- 3
Annual director equity award. Amount includes the following restricted share units granted by the Issuer, payable upon vesting in an equal number of common shares of the Issuer: (i) 20,107 restricted share units that are scheduled to vest on November 28, 2026; and (ii) 13,405 restricted share units that are scheduled to vest on September 15, 2027. Director fees paid in common shares.
Recent transactions
Voluntary purchases and sales; administrative noise stays hidden.
RACHESKY MARK H MD
Director
PurchaseAlert
- Shares
- 499,765
- Price
- —
- Value
- —
RACHESKY MARK H MD
Director
SaleAlert
- Shares
- 499,765
- Price
- —
- Value
- —
RACHESKY MARK H MD
Director
PurchaseAlert
- Shares
- 671,924
- Price
- —
- Value
- —
RACHESKY MARK H MD
Director
PurchaseAlert
- Shares
- 11,154,680
- Price
- —
- Value
- —
RACHESKY MARK H MD
Director
PurchaseAlert
- Shares
- 1,916,271
- Price
- —
- Value
- —
RACHESKY MARK H MD
Director
PurchaseAlert
- Shares
- 797,526
- Price
- —
- Value
- —
RACHESKY MARK H MD
Director
SaleAlert
- Shares
- 25,173,882
- Price
- —
- Value
- —
RACHESKY MARK H MD
Director
PurchaseAlert
- Shares
- 11,755,412
- Price
- —
- Value
- —
RACHESKY MARK H MD
Director
SaleAlert
- Shares
- 11,755,412
- Price
- —
- Value
- —
RACHESKY MARK H MD
Director
SaleAlert
- Shares
- 3,701,988
- Price
- —
- Value
- —
RACHESKY MARK H MD
Director
SaleAlert
- Shares
- 1,469,450
- Price
- —
- Value
- —
BURNS MICHAEL RAYMOND
Vice Chair
SaleAlert
- Shares
- 21,748
- Price
- $9.01
- Value
- $195,949
FELTHEIMER JON
Chief Executive Officer
SaleAlert
- Shares
- 195,000
- Price
- $8.28
- Value
- $1,614,600
Goldsmith Brian
Chief Operating Officer
SaleAlert
- Shares
- 25,000
- Price
- $8.54
- Value
- $213,500
| Date | Insider | Transaction | Shares | Price | Value | Reading |
|---|---|---|---|---|---|---|
| Jul 08, 2026 | RACHESKY MARK H MD Director | Purchase | 15,804,919 | — | — | |
| Jul 08, 2026 | RACHESKY MARK H MD Director | Purchase | 499,765 | — | — | |
| Jul 08, 2026 | RACHESKY MARK H MD Director | Sale | 499,765 | — | — | |
| Jul 08, 2026 | RACHESKY MARK H MD Director | Purchase | 671,924 | — | — | |
| Jul 08, 2026 | RACHESKY MARK H MD Director | Purchase | 11,154,680 | — | — | |
| Jul 08, 2026 | RACHESKY MARK H MD Director | Purchase | 1,916,271 | — | — | |
| Jul 08, 2026 | RACHESKY MARK H MD Director | Purchase | 797,526 | — | — | |
| Jul 08, 2026 | RACHESKY MARK H MD Director | Sale | 25,173,882 | — | — | |
| Jul 08, 2026 | RACHESKY MARK H MD Director | Purchase | 11,755,412 | — | — | |
| Jul 08, 2026 | RACHESKY MARK H MD Director | Sale | 11,755,412 | — | — | |
| Jul 08, 2026 | RACHESKY MARK H MD Director | Sale | 3,701,988 | — | — | |
| Jul 08, 2026 | RACHESKY MARK H MD Director | Sale | 1,469,450 | — | — | |
| Dec 23, 2025 | BURNS MICHAEL RAYMOND Vice Chair | Sale | 21,748 | $9.01 | $195,949 | |
| Dec 22, 2025 | FELTHEIMER JON Chief Executive Officer | Sale | 195,000 | $8.28 | $1,614,600 | |
| Dec 18, 2025 | Goldsmith Brian Chief Operating Officer | Sale | 25,000 | $8.54 | $213,500 |
“Alert” means a voluntary, unscheduled transaction according to the filing; it is not an investment recommendation. Official source: SEC EDGAR.